U.S. Marine and Shipping Stock News

American Express, NYSE:AXP, has announced plans to become the sole tenant of a new global headquarters at 2 World Trade Center in New York City. The company plans a state of the art tower focused on future ready technology, employee well being, and sustainability. The development is expected to play a meaningful role in the local economy and stand out as a major corporate real estate move within the financial sector. For investors watching NYSE:AXP, the new headquarters plan comes at a time...

Borr Drilling secured several contract extensions and new assignments for its jack-up rigs across Mexico, Brunei, the U.S., Gabon, Congo and Germany. The updates cover both existing contracts being extended and rigs moving to fresh work with different clients and regions. The new activity reflects continued use of Borr Drilling's jack-up fleet across a wider geographic footprint. Borr Drilling (NYSE:BORR) is drawing attention after these fresh contract wins, with the stock recently trading...

In recent days, American Eagle Outfitters has faced macro headwinds from new global import tariffs and inflation worries, while also announcing warehouse closures and winding down its Quiet Logistics third‑party services, resulting in 211 planned layoffs across two U.S. distribution centers. At the same time, analysts have become more optimistic about American Eagle’s earnings outlook and brand traction, supported by positive revenue trends and fresh marketing efforts like its expanded Jeans...

General Mills, NYSE:GIS, has reduced its full year sales and profit outlook as consumers shift toward lower priced private label products. The company is accelerating development of protein based offerings, aiming for a larger share of future revenue from this category. Senior leader Donald Monk is leaving General Mills to become Chief Technology Officer at Hormel Foods, marking a significant management change. General Mills shares recently closed at $45.23, with the stock down 21.7% over...

Amneal Pharmaceuticals (AMRX) has just posted its FY 2025 numbers, with Q4 revenue of US$814.3 million and basic EPS of US$0.11, capping a trailing twelve month run of US$3.0 billion in revenue and EPS of US$0.23. Over recent quarters the company has seen revenue move from US$702.5 million in Q3 2024 to US$730.5 million in Q4 2024, then to US$695.4 million, US$724.5 million, US$784.5 million and finally US$814.3 million through FY 2025, while quarterly EPS shifted from a loss of US$0.10 to...

Mondelez International (NasdaqGS:MDLZ) has appointed Ziad Abla as Managing Director for Mondelez Arabia. The new leadership role covers Saudi Arabia, one of the company’s key markets in the Middle East. Abla is set to oversee growth, commercial execution, and broader transformation initiatives in the region. For investors following NasdaqGS:MDLZ, this move sits within Mondelez International’s broader focus on snacks and confectionery across global markets, including the Gulf. Saudi Arabia...

The St. Joe Company reported past fourth-quarter 2025 results showing sales of US$60.7 million and revenue of US$128.9 million, with full-year 2025 revenue of US$513.25 million and net income of US$115.63 million, alongside a US$0.16 per-share dividend declaration and continued share repurchases. Recent expansions of its Watersound Real Estate platform and other asset-light businesses highlight St. Joe’s focus on growing recurring, service-based revenue linked to its Florida...

Abercrombie & Fitch (NYSE:ANF) is opening a new store at Pinecrest, expanding its physical retail presence. The brand’s Convertible Mesh Multiway Top is going viral on TikTok, driven by strong consumer interest. Abercrombie & Fitch, trading at around $97.65, comes into this news with mixed recent performance. The share price is down 21.1% year to date and 5.2% over the past year, while the 3 year and 5 year returns are both above 200%. For investors, that blend of recent pullback and longer...

Archrock (AROC) has drawn fresh attention after a recent move in its share price, with the stock now trading around $35.24. This has prompted investors to reassess its valuation and income profile. See our latest analysis for Archrock. The recent pullback in Archrock’s share price follows a strong run, including a 24.22% 30-day share price return and a 32.33% year-to-date share price return, along with a very large 5-year total shareholder return that reflects reinvested dividends and other...

DigitalBridge Group (NYSE:DBRG) released its latest quarterly financial results and paused regular quarterly guidance. The company decided not to host its usual earnings call, citing a proposed transaction with SoftBank Group Corp. The SoftBank proposal could lead to meaningful changes in DigitalBridge Group's business structure or ownership. DigitalBridge Group, a digital infrastructure investment firm, operates at the intersection of data centers, connectivity and related assets that...

Wondering if Ouster at around US$18.95 is still offering value after a volatile few years, or if most of the easy upside is already reflected in the price. The stock has been on a wild ride, with a 1.8% gain over the last 7 days, a 20.6% decline over 30 days, an 18.9% decline year to date, a 129.7% return over 1 year and a 69.2% return over 3 years, compared with an 84.2% decline over 5 years. Recent news coverage around Ouster has largely focused on its role in the lidar and sensor space...

Travelers Companies (TRV) has attracted fresh attention after launching its AI Claim Assistant, a voice based service built on OpenAI models that handles auto damage claim calls and related customer interactions. See our latest analysis for Travelers Companies. Those AI efforts come as the share price trades at US$308.64, with a 30 day share price return of 9.43% and a 1 year total shareholder return of 21.35%. This suggests sentiment has been improving. The longer term 5 year total...

Broadstone Net Lease (BNL) is back in focus after revealing two new build to suit projects: an industrial warehouse in Sarasota, Florida, and a retail development in Magnolia, Texas, totaling about US$62.1 million in planned investment. See our latest analysis for Broadstone Net Lease. The new Sarasota and Magnolia projects come on the heels of Broadstone Net Lease’s recent earnings update and dividend declaration, with the share price at US$19.43 and a 30 day share price return of 8.25%,...

Earlier this week, ONEOK reported fourth-quarter 2025 revenue of US$9.07 billion and net income of US$977 million, alongside full-year revenue of US$33.63 billion and net income of US$3.39 billion. Management paired these strong 2025 results and a 4% dividend increase with cautious 2026 guidance, highlighting volume growth but pressure from weaker commodity-related pricing. Next, we’ll examine how ONEOK’s strong 2025 performance but muted 2026 earnings outlook could influence its existing...

Dorman Products (DORM) drew investor attention after issuing 2026 earnings guidance calling for 7% to 9% net sales growth and higher diluted EPS, alongside a sizable goodwill impairment linked to its 2025 results. See our latest analysis for Dorman Products. The 1-day share price return of 1.35% to US$118.12 comes after the 2025 earnings release, goodwill impairment, and 2026 guidance. The 7-day share price return of 8.92% and 90-day share price return of 10.70% suggest momentum has cooled,...

Elanco Animal Health reported past fourth-quarter 2025 sales of US$1,144 million and full-year 2025 sales of US$4.72 billion, but moved from prior net income to a net loss of US$276 million for the quarter and US$232 million for the year. At the same time, Elanco exceeded revenue and adjusted earnings expectations, raised its 2026 innovation revenue outlook, announced the AHV International acquisition, and received USDA approval for Befrena, underscoring how product launches and portfolio...

Adams Diversified Equity Fund (ADX) has drawn fresh attention after reporting full year 2025 results, with revenue of US$32.79 million and net income of US$480.65 million. This provides investors with new data to assess the fund. See our latest analysis for Adams Diversified Equity Fund. The earnings release comes after a period where short term share price moves have been fairly muted, while a 1 year total shareholder return of 25.58% and 5 year total shareholder return of 118.76% point to...

ASML Holding increased the power output of its EUV lithography machines, enabling around 50% higher throughput and improved chip yields. This technical breakthrough is aimed at supporting chipmakers as they scale production of advanced components for next generation AI chips. ASML Holding, traded as NasdaqGS:ASML, sits at the center of high end chip manufacturing, and this latest EUV step reinforces its role as a critical supplier to leading foundries. The company’s shares recently closed...

If you are wondering whether Stock Yards Bancorp is attractively priced or just fairly valued at its current level, you are in the right place. The share price closed at US$64.14, with returns of a 7.5% decline over 7 days, a 5.2% decline over 30 days, a 1.6% decline year to date, and a 10.4% decline over 1 year, set against gains of 18.1% over 3 years and 31.9% over 5 years. These mixed returns give investors several entry and exit points to think about, especially if you are weighing...

Watsco (WSO) has given investors a mixed update, pairing softer fourth quarter and full year 2025 results with a 10% increase in its annual dividend to US$13.20 per share. See our latest analysis for Watsco. Following the softer 2025 results and higher dividend, Watsco's recent momentum has been positive, with a 1-month share price return of 8.36% and a 90-day share price return of 20.48%, even as the 1-year total shareholder return is negative 14.86% and the 5-year total shareholder return...

Oncolytics Biotech (NasdaqCM:ONCY) has finished enrolling patients in its GOBLET study evaluating pelareorep in gastrointestinal cancers. The company is now concentrating on pivotal registrational plans in rare cancers, including squamous cell anal cancer and metastatic colorectal cancer. An upcoming FDA meeting is expected to guide the design of a registrational trial for pelareorep. Oncolytics Biotech focuses on developing pelareorep, an immunotherapy candidate being tested across several...

Why BILL Holdings is on investors’ radar today BILL Holdings (BILL) is drawing attention after recent trading left the shares around $44.39, with returns under pressure over the past month, past 3 months, and year. See our latest analysis for BILL Holdings. The recent 1 day share price gain of 1.88% contrasts with a weaker trend, with the 90 day share price return of an 11.49% decline and a 1 year total shareholder return of a 19.58% loss suggesting momentum has been fading. If BILL’s recent...

Genesis Energy stock moves and recent return profile Genesis Energy (GEL) has drawn attention after a recent move in its unit price, prompting investors to take a closer look at how its recent returns line up with the fundamentals disclosed here. Over the past month, the stock shows a 4.6% return, with about 15.8% over the past 3 months and 13.7% year to date. On a 1 year basis, the total return figure stands at 46.8%, while the 3 year and 5 year total returns are 76.4% and approximately 16x...

Stepan (SCL) is back in focus after its latest earnings update, paired with Project Catalyst, a two year cost saving plan that includes plant closures, restructuring charges, and an ongoing dividend increase. See our latest analysis for Stepan. The share price reaction to Project Catalyst and the recent earnings miss has been sharp, with a 7 day share price return of a 24.3% decline and a 1 year total shareholder return showing a 15.12% loss. This points to fading momentum following a...